PLIANT THERAPEUTICS, INC. Other Non-Current Liabilities
PLIANT THERAPEUTICS, INC. (PLRX) had Other Non-Current Liabilities of $0 as of 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Balance Sheet › Liabilities
us-gaap:OtherLiabilitiesNoncurrent · last filed 2022-03-01
- 2021-12-31: Other Liabilities, Noncurrent $0.00.
- 2021-09-30: Other Liabilities, Noncurrent $756.00K.
- 2021-06-30: Other Liabilities, Noncurrent $804.00K.
- 2021-03-31: Other Liabilities, Noncurrent $835.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 |
| 2021-09-30 | $756.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $804.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $835.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $866.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $952.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $951.00K 10-Q · filed 2020-08-11 |
| 2019-12-31 | $912.00K 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |